The medical-products maker’s shares tumbled after its quarterly profit and sales underwhelmed investors.

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...

Novo Nordisk and Eli Lilly have generated billions of dollars in revenue selling weight loss drugs. Abbott Labs is launching a complementary product for those on the weight loss path. Abbott Labs is ...

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2025 as sales rose 4.4% year on year to $11.46 ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories has agreed to discontinue sales of its ...

Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous glucose monitor technology and put any patent disputes behind them for 10 years. North ...

Drugmakers Novo Nordisk and Eli Lilly have been making headlines in recent times, thanks to their sought-after weight loss drugs. In fact, the products have become so popular that demand has surpassed ...